Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 4
2014 4
2015 6
2016 6
2017 4
2018 2
2020 1
2021 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance.
Scaini MC, Catoni C, Poggiana C, Pigozzo J, Piccin L, Leone K, Scarabello I, Facchinetti A, Menin C, Elefanti L, Pellegrini S, Aleotti V, Vidotto R, Schiavi F, Fabozzi A, Chiarion-Sileni V, Rosato A. Scaini MC, et al. Among authors: fabozzi a. NPJ Precis Oncol. 2024 Mar 28;8(1):78. doi: 10.1038/s41698-024-00567-0. NPJ Precis Oncol. 2024. PMID: 38548846 Free PMC article.
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G, Fabricio ASC, Del Bianco P, Salizzato V, Favaretto A, Piccin L, Zustovich F, Fabozzi A, De Rossi C, Pigozzo J, De Nuzzo M, Cappelletto E, Bonanno L, Palleschi D, De Salvo GL, Guarneri V, Gion M, Chiarion-Sileni V. Pasello G, et al. Among authors: fabozzi a. J Transl Med. 2024 Mar 5;22(1):242. doi: 10.1186/s12967-024-04920-6. J Transl Med. 2024. PMID: 38443899 Free PMC article.
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations.
Cappelletto E, Fasiolo LT, Salizzato V, Piccin L, Fabozzi A, Contato A, Bianco PD, Pasello G, Chiarion-Sileni V, Gion M, Fabricio ASC. Cappelletto E, et al. Among authors: fabozzi a. Int J Biol Markers. 2024 Mar;39(1):9-22. doi: 10.1177/03936155231226234. Int J Biol Markers. 2024. PMID: 38407953 Free article.
Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143).
Rastrelli M, Del Fiore P, Russo I, Tartaglia J, Dal Monico A, Cappellesso R, Nicolè L, Piccin L, Fabozzi A, Biffoli B, Di Prata C, Ferrazzi B, Dall'Olmo L, Vecchiato A, Spina R, Russano F, Bezzon E, Cingarlini S, Mazzarotto R, Parisi A, Scarzello G, Pigozzo J, Brambullo T, Tropea S, Vindigni V, Bassetto F, Bertin D, Gregianin M, Dei Tos AP, Cavallin F, Alaibac M, Chiarion-Sileni V, Mocellin S. Rastrelli M, et al. Among authors: fabozzi a. Front Oncol. 2021 Dec 17;11:737842. doi: 10.3389/fonc.2021.737842. eCollection 2021. Front Oncol. 2021. PMID: 34976795 Free PMC article.
The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A, Cappellesso R, Dei Tos AP, Rossi V, Aliberti C, Pigozzo J, Fabozzi A, Sbaraglia M, Blandamura S, Del Bianco P, Chiarion-Sileni V, Rosato A. Tosi A, et al. Among authors: fabozzi a. J Exp Clin Cancer Res. 2021 May 4;40(1):154. doi: 10.1186/s13046-021-01947-1. J Exp Clin Cancer Res. 2021. PMID: 33947438 Free PMC article.
The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).
Elefanti L, Zamuner C, Del Fiore P, Stagni C, Pellegrini S, Dall'Olmo L, Fabozzi A, Senetta R, Ribero S, Salmaso R, Mocellin S, Bassetto F, Cavallin F, Tosi AL, Galuppini F, Dei Tos AP, Menin C, Cappellesso R. Elefanti L, et al. Among authors: fabozzi a. Int J Mol Sci. 2021 Apr 7;22(8):3826. doi: 10.3390/ijms22083826. Int J Mol Sci. 2021. PMID: 33917086 Free PMC article.
BRAF Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors.
Stagni C, Zamuner C, Elefanti L, Zanin T, Bianco PD, Sommariva A, Fabozzi A, Pigozzo J, Mocellin S, Montesco MC, Chiarion-Sileni V, De Nicolo A, Menin C. Stagni C, et al. Among authors: fabozzi a. Mol Cancer Ther. 2018 Jun;17(6):1332-1340. doi: 10.1158/1535-7163.MCT-17-1124. Epub 2018 Apr 6. Mol Cancer Ther. 2018. PMID: 29626128
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).
Orditura M, Gravina A, Riccardi F, Diana A, Mocerino C, Leopaldi L, Fabozzi A, Giordano G, Nettuno R, Incoronato P, Barzelloni ML, Caputo R, Pisano A, Grimaldi G, Genua G, Montesarchio V, Barbato E, Iodice G, Lieto E, Procaccini E, Mabilia R, Febbraro A, Laurentiis M, Ciardiello F. Orditura M, et al. Among authors: fabozzi a. ESMO Open. 2017 Jun 2;2(2):e000176. doi: 10.1136/esmoopen-2017-000176. eCollection 2017. ESMO Open. 2017. PMID: 28761747 Free PMC article.
28 results